Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions Beta-blocker Meningkatkan Harapan

Hidup dan Menurunkan Risiko Eksaserbasi Pasien PPOK Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial Cardioselective beta-blockers for chronic obstructive pulmonary disease Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise Treatment With Metoprolol Succinate, a Selective Beta Adrenergic Blocker, Lowers Blood Pressure Without Altering Insulin Sensitivity in Diabetic Patients
Expert consensus document on b-adrenergic receptor blockers

Khaled Albouaini Mohammed Andron Albert Alahmar Mohaned Egred

dr. Frans H. Rutten dkk. dari University Medical Center in Utrecht, Belanda,
Nathaniel M. Hawkins1*, Michael R. MacDonald2, Mark C. Petrie2, George W. Chalmers2, Roger Carter2, Francis G. Dunn3, and John J.V. McMurray4

Cardiothoracic Centre, Liverpool, England, UK

International Journal of COPD 2007:2(4) 535540

2007 Dove Medical Press Limited. All rights reserved

| JANUARI - FEBRUARI 2011

dipublikasikan dalam Archives of Internal Medicine Mei 2010. European Society of Cardiology

CDK Edisi 182 Januari 2011 oDRk.indd 43

Received 17 March 2009; revised 19 March 2009;

European Journal of Heart Failure (2009) 11, 684690

Shelley R Salpeter1, Thomas M Ormiston2, Edwin E Salpeter3 C. L. Chang, G. D. Mills, J. D. McLachlan, N. C. Karalus and R. J. Hancox

2008 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.

Respiratory Research Unit, Department of Respiratory Medicine, Waikato Hospital, Hamilton, New Zealand

Cochrane Database of Systematic Reviews 2005

Internal Medicine Journal 40 (2010) 193 200

Bonita Falkner, MD;1 Harvey Kushner, PhD2

(J Clin Hypertens (Greenwich). 2008;10:5157)

VOL. 10 NO. 1 January 2008

THE Journal of Clinical Hypertension